TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $855,367,000 | +38.3% | 11,367 | -50.6% | 0.00% | 0.0% |
| Q1 2022 | $618,329,000 | -58.4% | 23,029 | -26.1% | 0.00% | -50.0% |
| Q4 2021 | $1,487,191,000 | +98.8% | 31,178 | +176.9% | 0.00% | +100.0% |
| Q3 2021 | $748,068,000 | +119.6% | 11,261 | +157.9% | 0.00% | – |
| Q2 2021 | $340,713,000 | -27.9% | 4,367 | -12.6% | 0.00% | -100.0% |
| Q1 2021 | $472,477,000 | -85.5% | 4,995 | -81.4% | 0.00% | -83.3% |
| Q4 2020 | $3,268,992,000 | +363.6% | 26,828 | +232.4% | 0.01% | +500.0% |
| Q3 2020 | $705,170,000 | +234.3% | 8,072 | +147.2% | 0.00% | – |
| Q2 2020 | $210,951,000 | -66.3% | 3,266 | -76.7% | 0.00% | -100.0% |
| Q1 2020 | $625,508,000 | +166.3% | 14,006 | +271.4% | 0.00% | – |
| Q4 2019 | $234,896,000 | +558.3% | 3,771 | +297.4% | 0.00% | – |
| Q3 2019 | $35,682,000 | +517.4% | 949 | +568.3% | 0.00% | – |
| Q2 2019 | $5,779,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |